Streetbeat News

Analyst Ratings

PFE

Pfizer's (NYSE:PFE) short percent of float has risen 7.14% since its last report, with 59.51 million shares sold short, which is 1.05% of all regular shares available for trading. It would take traders 1.85 days to cover their short positions on average. An increase in short interest can signal that investors have become more bearish. Pfizer's peer group average for short interest as a percentage of float is 3.67%, which means the company has less short interest than most of its peers.

Portfolio Pulse from Benzinga Insights

July 13, 2023 | 2:30 pm

YUM

Yum Brands's (NYSE:YUM) short percent of float has risen 15.34% since its last report, with 5.68 million shares sold short, which is 2.03% of all regular shares available for trading. It would take traders 2.64 days to cover their short positions on average. The company's short interest is less than its peer group average of 8.88%.

Portfolio Pulse from Benzinga Insights

July 13, 2023 | 2:30 pm

RTX

Raytheon Technologies (NYSE:RTX) has seen a decrease in its short percent of float by 10.81% since its last report, with 9.68 million shares sold short. This represents 0.66% of all regular shares available for trading. The short interest in Raytheon Technologies is less than its peer group average of 3.52%. Short interest can act as an indicator of market sentiment towards a stock.

Portfolio Pulse from Benzinga Insights

July 13, 2023 | 2:30 pm

AAPL

MSFT

QQQ

SPY

TSLA

The Market Clubhouse Morning Memo discusses trade strategies for SPY, QQQ, AAPL, MSFT, and TSLA. The memo provides price levels for these assets based on a proprietary formula that considers price, volume, and options flow. The memo suggests potential breakouts or reversals for these stocks and advises traders to adjust their tactics based on the market's pulse.

Portfolio Pulse from RIPS

July 13, 2023 | 2:29 pm

AMZN

Tigress Financial analyst Ivan Feinseth has reiterated a 'Buy' rating on Amazon.com (NASDAQ:AMZN) and raised the price target from $192 to $204.

Portfolio Pulse from Benzinga Newsdesk

July 13, 2023 | 2:28 pm

PBAM

Piper Sandler analyst Matthew Clark has assumed Private Bancorp (OTC:PBAM) with an Overweight rating and set a price target of $35.

Portfolio Pulse from richadhand@benzinga.com

July 13, 2023 | 2:24 pm

OTLK

Capital One analyst Zegbeh Jallah has initiated coverage on Outlook Therapeutics (NASDAQ:OTLK) with an Overweight rating and a price target of $5.

Portfolio Pulse from richadhand@benzinga.com

July 13, 2023 | 2:23 pm

UNH

UBS analyst Kevin Caliendo has maintained a Neutral rating on UnitedHealth Group (NYSE:UNH) and lowered the price target from $550 to $510.

Portfolio Pulse from richadhand@benzinga.com

July 13, 2023 | 2:21 pm

NBIX

UBS analyst Ashwani Verma maintains a 'Buy' rating on Neurocrine Biosciences (NASDAQ:NBIX) but lowers the price target from $121 to $115.

Portfolio Pulse from richadhand@benzinga.com

July 13, 2023 | 2:20 pm

HUM

UBS analyst Kevin Caliendo has maintained a 'Buy' rating on Humana (NYSE:HUM) but lowered the price target from $620 to $560.

Portfolio Pulse from richadhand@benzinga.com

July 13, 2023 | 2:19 pm